Introduction
A defining characteristic of cancer cells is the ability to proliferate beyond the lifespan allotted to a normal somatic cell. The finite lifespan of human somatic cells is attributed to a gradual loss of telomeric DNA during each cell division, which ultimately leads to a growth arrest (Harley et al., 1990; Hastie et al., 1990) , and in the case of transformed cells, even cell death (Counter et al., 1992) . Cancer cells surmount this proliferative barrier by counteracting telomere shortening, primarily by the induction of telomerase activity (Counter et al., 1994; Kim et al., 1994) . This enzyme elongates telomeres through the transcriptional reactivation of the hTERT gene, which encodes its catalytic subunit (Kilian et al., 1997; Meyerson et al., 1997; Nakamura et al., 1997; Harrington et al., 1997) . Indeed, ectopic expression of hTERT reportedly immortalizes many different cultured somatic (Bodnar et al., 1998; Vaziri and Benchimol, 1998; Harley, 2002) or virally transformed human cells Farwell et al., 2000; Halvorsen et al., 1999; Kiyono et al., 1998; Zhu et al., 1999) . Telomerase activity has been detected in the vast majority of human cancers, although the level of this activity can vary widely (reviewed in Shay and Bacchetti, 1997) . In addition, low levels of telomerase activity or hTERT transcripts have also been detected in a number of normal somatic cells types (Broccoli et al., 1995; Buchkovich and Greider, 1996; Counter et al., 1995; Harle-Bachor and Boukamp, 1996; Kolquist et al., 1998; Norrback et al., 1996; Yasumoto et al., 1996) . Given that low levels of enzyme activity or hTERT transcripts have been detected in both normal and malignant cells, we wished to determine experimentally what level of telomerase activity accounts for the ability of this enzyme to permit tumourigenic growth.
We therefore took advantage of a series of hTERT substitution mutants that we had created which induced varying levels of telomerase catalytic activity when expressed in human cells. Here, six amino acid segments in the C-terminus of hTERT were substituted with the amino acids NAAIRS (Banik et al., 2002) . This sequence is found in a variety of protein structures and hence has been used in mutational analyses of proteins, as substitution with NAAIRS will alter protein sequence but presumably not alter global protein folding (Armbruster et al., 2001; Sellers et al., 1998; Banik et al., 2002) . The resultant constructs were stably expressed in mortal human embryonic kidney (HEK) cells transformed with the SV40 large T-Ag gene, encoding the oncoproteins large and small T antigen. These transformed HEK cells express hTR but lack detectable levels of hTERT mRNA and telomerase activity (Counter et al., 1992; Meyerson et al., 1997) . Hence they continually lose telomeric DNA until a critically short telomere length provokes genetic instability and cell death (Counter et al., 1992) . However, ectopic expression of hTERT restores enzyme activity, stabilizes telomere length and extends the lifespan of these cells, providing a model system to assess both the biochemical and biological functions of hTERT (Armbruster et al., 2001; Counter et al., 1998) . As described elsewhere (Banik et al., 2002) , the panel of C-terminal hTERT mutants was stably introduced into these T-Ag transformed HEK cells by retroviral infection, creating a series of polyclonal cell lines. Polyclonal populations have the distinct advantage of being composed of hundreds to thousands of independently infected cells, circumventing the problem of variation associated with clonal cell lines. Extracts were then isolated from these cells and assayed for telomerase activity, identifying mutants that restored different levels of telomerase activity.
To assess whether levels of telomerase activity affect the tumourigenic process we chose specific mutants from the described panel that restored varying levels of telomerase activity. As previously described (Banik et al., 2002) , cells expressing hTERT NAAIRS with substitutions at position +1022 or +1100 had activity similar to the wildtype telomerase enzyme, as demonstrated by the heat sensitive six base pair ladder of elongation products (Kim and Wu, 1997) . Hence, these cells were considered to have high levels of telomerase activity. On the other hand, a medium level of enzyme activity (corresponding to approximately half of the wildtype level), was demonstrated by hTERT mutants with substitutions at positions +914 and +1052. Less than 5% activity was designated as low activity as exemplified by mutants with substitutions at positions +1118 and +1064 (Figure 1a ,b). Finally, some mutations were shown to completely abrogate enzyme activity as shown by mutants +902 and +1088. The level of telomerase activity demonstrated by the mutants was highly reproducible, with similar levels of activity being obtained from extracts made from three independently derived cell lines for each mutant ( Figure 1b) . In addition, extracts tested at early and late passages, also demonstrated similar levels of activity (not shown).
In the case of mutants with reduced activity, we discount possible PCR inhibitory effects of cellular components since an internal standard was readily amplified (Figure 1a ). The reduction in activity was also unlikely to be due to instability of hTERT mutant proteins as the mutated hTERT transgenes produced protein at similar levels when transiently expressed in human cells. Lastly, the activity detected in the cells stably infected with the described constructs was ascribed exclusively to the mutant protein since cells expressing the transcripts derived from these constructs did not express the endogenous hTERT gene ( Figure  1c and not shown).
Mutants that restored high or medium levels of telomerase activity displayed identical growth curves to cells expressing wildtype hTERT. These data suggest that the amount of telomerase activity actually required for cellular immortalization can be greatly attenuated. However, there is a limit; a reduction of telomerase activity to less than 5% of wildtype failed to immortalize the cells (Figure 1d and Banik et al., 2002) . Thus, there is a threshold of telomerase enzyme activity required for the tumour cell phenotype of an immortal lifespan. We confirmed that telomerase activity was correlated with biological telomere function. In cells expressing low or no telomerase activity, telomere shortening was observed by Southern blot analysis. On the other hand, cells at late passage with medium and high levels of telomerase activity had stabilized telomere length (data not shown and Banik et al., 2002) .
We and others have shown that ectopic expression of the T-Ag gene, oncogenic (val12) H-Ras and hTERT is sufficient to allow normal primary human fibroblasts, astrocytes, HEK cells or mammary epithelial cells to acquire fundamental characteristics of cancer cells, including the ability to grow in soft agar and form tumours when injected into immunocompromised mice (Elenbaas et al., 2001; Hahn et al., 1999; Rich et al., 2001) . This system therefore provides the means to directly test the minimum level of telomerase activity required for transformation and tumourigenesis through the use of the aforementioned hTERT mutants in co-operation with the T-Ag gene and H-Ras val12 . Two independent hTERT mutants that restore high, medium, or low telomerase activity were stably introduced by retroviral infection into primary HEK cells expressing the T-Ag gene, either in the absence or presence of H-Ras val12 . HEK cells expressing T-Ag and H-Ras val12 were also infected with an empty vector or one encoding mutant hTERT transgenes that fail to restore any telomerase activity to serve as a negative control, or a vector encoding wildtype hTERT to serve as a positive control for soft agar assays. Extracts were isolated from the resultant cell lines, resolved by SDS -PAGE and immunoblotted with an anti-Ras antibody to confirm ectopic H-Ras val12 expression in cells that received the vector encoding H-Ras val12 (Figure 2) . Having confirmed that H-Ras val12 was appropriately expressed, we next assayed whether a minimum level of telomerase activity is required for anchorage-independent growth. Anchorage-independent growth is one of the most rigorous tests of cellular transformation in vitro and provides the best correlate to tumourigenic growth potential. Using this assay we addressed the importance of telomerase activity for transformation. As a control, we first confirmed that the T-Ag gene and H-Ras val12 did not transform primary HEK cells, whereas the addition of wildtype hTERT to these cells was sufficient to promote anchorage-independent growth (Table 1) . Having confirmed that HEK cells depend upon hTERT, T-Ag and H-Ras val12 for growth in semi-solid media, we next determined whether human cells in the presence of the T-Ag gene and HRas val12 required a minimum level of telomerase activity to form colonies in soft agar. We find that HEK cells expressing T-Ag and H-Ras val12 in the presence of independent mutants that restored either high (+1022, +1100) or medium (+914, +1052) levels of telomerase activity grew in an anchorageindependent fashion similar to cells expressing wildtype hTERT (Table 1) . As expected, this growth was lost in the absence of H-Ras val12 . However, a further reduction of telomerase activity to less than 5% of wildtype abolished the ability of these cells to grow in a semisolid medium (Table 1 ). Specifically, the described HEK cells expressing hTERT mutants +1064 or +1118, which restore low levels of telomerase activity, failed to grow in soft agar, as did the same cells expressing mutants that are catalytically inactive (+1088, +902). Thus, there exists a minimum level of telomerase activity required to collaborate with the T-Ag gene and H-Ras val12 to promote anchorage- Figure 1 A minimum level of telomerase activity is required for cellular immortalization. (a) The sequence of N-terminal FLAGtagged hTERT at the indicated amino acid positions was substituted for the nucleotides encoding the amino acids NAAIRS by site directed mutagenesis, after which the mutated cDNAs were subcloned into the pBabehygro retroviral vector, as described previously (Banik et al., 2002) . Amphotrophic retroviruses were generated from these vectors, or pBabehygro alone or encoding wildtype FLAG-tagged hTERT, were used to stably infect HEK cells expressing T-Ag (Stewart and Bacchetti, 1991), as previously described (Armbruster et al., 2001) . Telomerase activity was assayed from 0.2 mg of extract isolated from early passage of polyclonal cell populations selected in 100 mg/ml of hygromycin, as previously described (Kim and Wu, 1997) . The activity of cells expressing hTERT mutant +1118 is also shown at a longer exposure. As a control, extracts were heat treated (HT) at 858C for 5 min to inactivate telomerase. IS, internal PCR standard. (b) Telomerase activity assayed from three independently generated cell lines was determined by measuring the intensity of the first six elongation products by phosphorimager analysis. Mean activity was normalized and expressed as per cent activity when compared with the cell line expressing wildtype FLAG-hTERT. (c) The same hTERT cDNAs were subcloned into the vector pCI-neo, and the resultant constructs, or the vector alone, were transiently transfected into 293 human cells using the Fugene reagent (Roche) according to the manufacturer's instructions. 30 mg of soluble lysate prepared from the cells 48 h later was resolved by SDS -PAGE and immunoblotted with the M2 anti-FLAG antibody (Sigma), as previously described (Armbruster et al., 2001) . Actin, detected with the C2 anti-actin antibody (Santa Cruz Biotechnology, Inc), serves as a loading control. (d) The culture growth in mean population doublings (pds) versus time in days is plotted for the described HEK-T-Ag cell lines stably infected with a vector control retrovirus (open square), or one encoding wildtype hTERT (open circle) or the NAAIRS mutants +1022, +914 or +118 that restore high (closed circle), medium (closed square), or low (closed triangle)levels of telomerase activity, respectively independent growth, a key feature of tumourigenic cells.
As suggested by colony formation in soft agar, it appeared that the mere detection of telomerase activity in cells may not be sufficient to permit tumourigenic growth. To more rigorously investigate the consequence of telomerase activity on tumour formation in vivo, we injected HEK cells expressing T-Ag, H-Ras val12 and a mutant of hTERT that restored high, medium low or no telomerase activity, a wildtype hTERT or a vector alone into four immuno-compromised mice. We find cells expressing mutants that restored medium to high levels of telomerase activity formed tumours, whereas cells expressing mutants that restored less than 5% enzyme activity, like the vector control, were unable to promote tumourigenic growth (Table 2) . Thus the level of telomerase activity can be greatly attenuated without a demonstrable effect on tumourigenic potential; however, a reduction to less than 5% activity was unable to support tumourigenesis.
In conclusion, we find complete concordance among cancer characteristics of cellular immortalization, transformation, tumourigenic growth, and the level of telomerase activity. While all of these tumour processes can occur at levels considerably below that of cells expressing wildtype hTERT, a reduction of assayable enzyme activity below 5% abolished the ability of human cells to acquire each of these tumour phenotypes. We recognize that mutants of hTERT that alter enzyme activity could perturb other functions of the enzyme. In fact, a mutation or the addition of an epitope tag to the extreme C-terminus of the protein reduces enzyme catalytic activity somewhat, but completely abrogates the ability of the hTERT to immortalize cells Halvorsen et al., 1999; Ouellette et al., 1999; Zhu et al., 1999; Banik et al., 2002) . However, we submit that by using two mutants from different regions of the hTERT that the change of affecting multiple functions of telomerase with every mutant is unlikely. Lastly, the fact that hTERT mutants that reconstitute low levels of Figure 2 Oncogenic Ras expression in cells with increasing levels of telomerase activity. Oncogenic (val12) H-Ras was subcloned into the retroviral vector pBabepuro, and the resultant construct, or the pBabepuro vector alone was introduced into HEK-T-Ag cells stably infected with either pBabehygro (vector), pBabehygro FLAG-hTERT or the described hTERT mutants by retroviral infection, as previously described (Armbruster et al., 2001) . 30 mg of soluble lysate derived from the early passage of polyclonal populations selected in media supplemented with 0.5 mg/ml of puromycin were resolved by SDS -PAGE and immunoblotted with the Ab3 anti-pan-ras antibody (Oncogene Research). Actin, detected with the C2 anti-actin antibody (Santa Cruz Biotechnology, Inc), serves as a loading control (vector) or pBabehygro FLAG-hTERT containing the described NAAIRS substitution mutations were injected subcutaneously into the flanks of 4 SCID/Beige mice and scored for tumour growth over a period of 2 months. {One animal was euthanized shortly after injection, and hence only three mice were monitored for tumour growth in this set. telomerase activity were unable to recapitulate the tumour characteristics of immortalization, anchorageindependent growth and tumour growth in mice, corroborates the observation that somatic cells with low levels of telomerase activity such as hematopoietic cells are mortal and lose telomeric DNA in vitro and in vivo (Norrback and Roos, 1997) . Thus, low levels of activity detected in such cells is not expected to contribute to tumourigenic growth. Lastly, the mere detection of telomerase in human tumours also does not necessarily signify a biologically relevant level of enzyme activity.
